Anifrolumab real-world treatment outcomes in Polish patients with
systemic lupus erythematosus (SLE). Multicenter, non-interventional study.

We would like to invite you to participate in a Polish multicenter observational (non-interventional), open-label study designed to document the clinical outcomes and characteristics of patients suffering from systemic lupus erythematosus (SLE) who received anifrolumab in the scope of routine clinical practice within the frames of National Drug Program. The registration and login panel for the eCRF system is available on the right.